Meeting
2023 ASCO Annual Meeting
The genomic, transcriptomic, and immunological landscape of SGLT2 in lung cancer.
Authors
Heng Tan
University of Miami/Jackson Memorial Hospital, Miami, FL
Heng Tan , Samuel A. Kareff , Harris Benjamin Krause , Asaad Trabolsi , Andrew Elliott , Alex Patrick Farrell , Stephen V. Liu , Patrick C. Ma , Ari M. Vanderwalde , Milan Radovich , George W. Sledge Jr., Gilberto Lopes
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Lung Cancer—Non-Small Cell Metastatic
Track
Lung Cancer
Sub Track
Biologic Correlates
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 9027)
DOI
10.1200/JCO.2023.41.16_suppl.9027
Abstract #
9027
Poster Bd #
15
Abstract Disclosures
Similar Posters
First Author: Sandra Algaze
Poster
2022 ASCO Annual Meeting
Differential prognostic effect of systemic inflammation in patients with NSCLC treated with immunotherapy or chemotherapy: A post hoc analysis of the phase III OAK trial.
First Author: Alessio Cortellini
Poster
2021 ASCO Annual Meeting
Genomic and immunologic characterization of large-cell neuroendocrine carcinoma of the lung.
First Author: Chul Kim
Poster
2023 ASCO Annual Meeting
Real-world outcomes of first-line immune checkpoint inhibitors with or without chemotherapy in KRAS G12C altered NSCLC according to PD-L1 status.
First Author: Charu Aggarwal